These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women. Vanakoski J; Strömberg C; Seppälä T Eur J Clin Pharmacol; 1993; 45(4):377-81. PubMed ID: 8299674 [TBL] [Abstract][Full Text] [Related]
3. The effects of midazolam and ephedrine on post-exercise autonomic chronotropic control of the heart in normal subjects. Lindqvist A; Jalonen J; Laitinen LA; Seppälä T; Strömberg C Clin Auton Res; 1996 Dec; 6(6):343-9. PubMed ID: 8985623 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects. Berlin I; Warot D; Aymard G; Acquaviva E; Legrand M; Labarthe B; Peyron I; Diquet B; Lechat P Eur J Clin Pharmacol; 2001 Sep; 57(6-7):447-55. PubMed ID: 11699608 [TBL] [Abstract][Full Text] [Related]
5. 150 mg fluconazole does not substantially increase the effects of 10 mg midazolam or the plasma midazolam concentrations in healthy subjects. Vanakoski J; Mattila MJ; Vainio P; Idänpään-Heikkilä JJ; Törnwall M Int J Clin Pharmacol Ther; 1995 Sep; 33(9):518-23. PubMed ID: 8520811 [TBL] [Abstract][Full Text] [Related]
12. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. White LM; Gardner SF; Gurley BJ; Marx MA; Wang PL; Estes M J Clin Pharmacol; 1997 Feb; 37(2):116-22. PubMed ID: 9055137 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793 [TBL] [Abstract][Full Text] [Related]
15. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668 [TBL] [Abstract][Full Text] [Related]
16. Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Backman JT; Olkkola KT; Ojala M; Laaksovirta H; Neuvonen PJ Epilepsia; 1996 Mar; 37(3):253-7. PubMed ID: 8598183 [TBL] [Abstract][Full Text] [Related]
17. Meptazinol and pentazocine: plasma catecholamines and other effects in healthy volunteers. Manner T; Kanto J; Scheinin H; Scheinin M Br J Clin Pharmacol; 1987 Dec; 24(6):689-97. PubMed ID: 3440093 [TBL] [Abstract][Full Text] [Related]
18. Selected cardiac and metabolic responses to pseudoephedrine with exercise. Bright TP; Sandage BW; Fletcher HP J Clin Pharmacol; 1981; 21(11):488-92. PubMed ID: 7037866 [TBL] [Abstract][Full Text] [Related]
19. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam. Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107 [TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers. McCormick AS; Thomas VL; Berry D; Thomas PW Br J Anaesth; 2008 May; 100(5):631-6. PubMed ID: 18385262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]